INTEGRA Biosciences’ pipettes pave the way for epigenetics testing

Genknowme, a start-up specializing in epigenetics research, has integrated multichannel pipettes from INTEGRA Biosciences into its liquid handling workflows. These liquid handling solutions will enable the lab to provide fast epigenetic assessments that will support healthcare professionals in suggesting lifestyle changes to improve their patients’ quality of life.

Genknowme, in Lausanne, Switzerland, was founded to investigate how environmental and behavioral factors can reversibly modify gene expression. The company has developed a unique blood test that provides a comprehensive, personalized epigenetic health assessment indicating a person’s biological age, which can be used to inform preventative lifestyle changes for healthier aging.

The team acquired two 8 channel VOYAGER adjustable tip spacing pipettes – one 12.5 μl and one 125 μl – to streamline its liquid handling protocols and minimize human error. , 

Epigenetics research can be a complex and time-consuming process, so we are always looking for ways to increase our throughput for faster and more accurate results. We incorporated VOYAGER pipettes into our laboratory to allow transfer of multiple samples at once between different labware formats, minimizing the number of liquid handling steps in our workflows. This gives us a competitive advantage over similar companies – by improving our efficiency and quality – and we can also program our protocols onto the pipettes, which helps with consistency and saves us additional time.”

Dr Laurence Chapatte, Chief Technology Officer, Genknowme

The group is also planning to introduce automation into the lab in the near future by purchasing an ASSIST PLUS pipetting robot, which can be combined with VOYAGER pipettes to enhance the accuracy and reproducibility of routine pipetting tasks. Introducing automation into the laboratory will further reduce the team’s hands-on time, freeing them up to focus on incorporating different biomarkers – such as those indicating stress – into the existing testing panel. “This emerging area of science holds immense potential for a new era of medicine focused on holistic, personalized and preventative care. We hope to make epigenetics testing affordable and accessible for a larger population, and INTEGRA’s solutions will help us to achieve this goal,” Laurence concluded.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    INTEGRA Biosciences. (2024, September 17). INTEGRA Biosciences’ pipettes pave the way for epigenetics testing. News-Medical. Retrieved on October 11, 2024 from https://www.news-medical.net/news/20240917/INTEGRA-Biosciencese28099-pipettes-pave-the-way-for-epigenetics-testing.aspx.

  • MLA

    INTEGRA Biosciences. "INTEGRA Biosciences’ pipettes pave the way for epigenetics testing". News-Medical. 11 October 2024. <https://www.news-medical.net/news/20240917/INTEGRA-Biosciencese28099-pipettes-pave-the-way-for-epigenetics-testing.aspx>.

  • Chicago

    INTEGRA Biosciences. "INTEGRA Biosciences’ pipettes pave the way for epigenetics testing". News-Medical. https://www.news-medical.net/news/20240917/INTEGRA-Biosciencese28099-pipettes-pave-the-way-for-epigenetics-testing.aspx. (accessed October 11, 2024).

  • Harvard

    INTEGRA Biosciences. 2024. INTEGRA Biosciences’ pipettes pave the way for epigenetics testing. News-Medical, viewed 11 October 2024, https://www.news-medical.net/news/20240917/INTEGRA-Biosciencese28099-pipettes-pave-the-way-for-epigenetics-testing.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Everything you need to know about next generation sequencing in INTEGRA Biosciences’ eBook